Press release
Surgery Partners, Inc. (NASDAQ: SGRY) Investor Investigation over potential Wrongdoing
An investigation on behalf of investors in Surgery Partners, Inc. (NASDAQ: SGRY) shares over potential wrongdoing.
Investors who purchased shares of Surgery Partners, Inc. (NASDAQ: SGRY) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Surgery Partners, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Surgery Partners, Inc. reported that its annual Total Revenue rose from over $1.34 billion in 2017 to over $1.77 billion in 2018 and that its Net Loss increased from $52.98 million in 2017 to $205.7 million in 2018.
Shares of Surgery Partners, Inc. (NASDAQ: SGRY) closed on January 24, 2020, at $18.07 per share.
Those who purchased shares of Surgery Partners, Inc. (NASDAQ: SGRY) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surgery Partners, Inc. (NASDAQ: SGRY) Investor Investigation over potential Wrongdoing here
News-ID: 2032114 • Views: …
More Releases from Shareholders Foundation
Ardent Health, Inc. (NYSE: ARDT) Investor Alert: Deadline in Lawsuit on March 09 …
A deadline is coming up on March 09, 2026 in the lawsuit filed for certain investors of Ardent Health, Inc. (NYSE: ARDT) over alleged securities laws violations by Ardent Health, Inc.
Investors who purchased shares of Ardent Health, Inc. (NYSE: ARDT) have certain options and there are strict and short deadlines running. Deadline: March 09, 2026. Ardent Health, Inc. (NYSE: ARDT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Sina Corporation (formerly NASDAQ: SINA) Investor Alert: Investigation of potent …
An investigation on behalf of investors in shares of Sina Corporation (formerly NASDAQ: SINA) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors inSina Corporation (formerly NASDAQ: SINA shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in Sina Corporation (formerly NASDAQ:…
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
More Releases for Surgery
Dental Surgery Conference | Dental Surgery Congress | Chicago | USA
Dental Surgery 2024We are delighted to invite dental professionals from all over the world to join us for an exceptional and comprehensive dental conference the 40th International Conference on Dental Surgery and Medicine. This event is designed to facilitate knowledge sharing, networking, and exploration of the latest advancements in the field of dentistry.
Theme: "A better life starts with a beautiful smile"
Date: June 06-07, 2024
Venue: Chicago,USA
Chicago,USA
CHICAGO
Dental Surgery 2024We are delighted to…
Intraoperative Neuromonitoring Market Size to Hit Valuation of $4.90 Billion by …
IONM would improve intraoperative decision-making, by guiding a surgeons hands during surgery to reduce potential neurological risk. This benefits patients with a better surgical outcome and reduces a surgeons liability to a great extent.
Global Intraoperative Neuromonitoring (IONM) Market was valued at $3,036 million in 2015, and is projected to reach $4,900 million by 2022, growing at a CAGR of 7% from 2016 to 2022, according to a new report published…
Hemostats Market Research Insights by Major Applications Survey on cardiovascula …
Hemostasis is the course of blood clotting. Blood clotting plays a vital role in various surgeries by achieving positive outcomes with the reduction of blood loss. This clotting process reduces the surgery time and the need for blood transfusion.
Thus, hemostats are surgical instruments used to regulate the bleeding during surgery. Hemostats are also used for oozing out venomous bleeds, bone bleeding, and others. The scope of hemostats is growing rapidly…
Europe Data for Surgeries by Surgery Type (Hip Implant, Major Peritoneal Surgery …
The number of hip implant surgeries, major peritoneal surgeries, thoracic surgeries, and ENT surgeries along with the surgeries for central nervous system (CNS), in Europe were valued at 35,860 thousand procedures in 2016 and is projected to reach 41,818 thousand procedures by 2023. The study includes number of hip implants and major peritoneal, thoracic, CNS, and ENT surgeries performed in Europe. In addition, the report includes other relevant details for…
Surgical Robotics Market Growth Study by Component [Systems, Accessories and Ser …
Robotic surgery is a type of minimally invasive surgery which utilizes robotics for performing surgical procedures. These robotic systems are operated by surgeons and consists of miniaturized surgical instruments which are mounted on robotic arms, thus allowing surgeons to perform the surgeries precisely. The global surgical robotics market was valued at $56,294.9 million in 2017, and is expected to reach $98,737.0 million by 2024 at a CAGR of 8.5% during…
Surgical Robotics Market Report 2018: Segmentation by Component (Systems, Access …
Global Surgical Robotics market research report provides company profile for Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Intuitive Surgical, Inc., KUKA AG, Stryker Corporation (MAKO Surgical Corp.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
